Vigil Neuroscience · pitchdeck
Vigil Neuroscience | IPO Presentation Deck | 54 slides
54 pages · 4 arc beats · 2 loops
Vigil Neuroscience | IPO Presentation Deck | 54 slides
Vigil Neuroscience · 2022-01 arc beats above · slides in the middle · loops below · scroll → 2 LOOPS
124681012141618202224262830323436384042444648505254
Deck intelligence map
4 coverage by narrative range · generated from this deck JSON
Narrative range 21 total
Metadata
Components
Metrics
Tools
Frameworks
Beats
Loops
Problem 8 slides 100% 8/8 slides 100% 8/8 slides · 43 hits — 0/8 slides
100% 8/8 slides · 9 hits 37.5% 3/8 slides 100% 8/8 slides 100% 8/8 slides Solution 11 slides 100% 11/11 slides 100% 11/11 slides · 50 hits — 0/11 slides
— 0/11 slides
18.2% 2/11 slides 100% 11/11 slides — 0/11 slides
Market Size 1 slides 100% 1/1 slides 100% 1/1 slides · 4 hits — 0/1 slides
100% 1/1 slides 100% 1/1 slides 100% 1/1 slides — 0/1 slides
Why Now 1 slides 100% 1/1 slides 100% 1/1 slides · 6 hits — 0/1 slides
— 0/1 slides
100% 1/1 slides 100% 1/1 slides — 0/1 slides
Slide inventory
54 every slide · same image gating as the playbook
06
The slide uses a standard team bio layout with headshots, titles, and a logo grid of past company experience.other
08
The slide presents the Scientific Advisory Board members with headshots and credentials.other
09
Uses a Venn-diagram style overlapping circle visualization to represent expansion strategy.plan_implementation
10
The slide emphasizes exclusivity in the development pipeline for both modalities.present_solution
Open slide detailBeat · Solution
11
The slide uses a standard pharmaceutical pipeline Gantt-style visualization.plan_implementation
Open slide detailBeat · Solution
13
The slide uses a central illustration of a microglial cell with radiating labels describing its functions.present_solution
Open slide detailBeat · Solution
14
Scientific diagram showing receptor activation upon binding to debris.present_solution
Open slide detailBeat · Solution
15
The slide uses a branching process diagram to contrast healthy vs. dysfunctional microglial pathways.establish_context
Open slide detailBeat · Solution
17
The slide uses a honeycomb-style layout to present five key product attributes.present_solution
Open slide detailBeat · Solution
18
The data demonstrates target engagement via IP-10 induction, a biomarker for TREM2 activation.show_traction
Open slide detailBeat · Solution
19
The slide uses box plots to compare control vs mVGL101 groups across six different gene expression categories.analyze_data
Open slide detailBeat · Solution
20
NHP = non-human primates. Data shows dose-dependent serum concentration and CSF target engagement.show_traction
Open slide detailBeat · Solution
21
The slide features the company logo and a molecular structure illustration.transition
22
The slide uses a hub-and-spoke diagram where ALSP is the central hub, surrounded by four strategic pillars.establish_context
Open slide detailBeat · Why Now
23
The slide uses a 2x2 grid layout to categorize disease information.frame_problem
24
The diagram shows the molecular mechanism of cell signaling across the cell membrane.establish_context
25
The slide uses a comparison matrix to establish a biological rationale for targeting these pathways.compare_peers
26
The slide uses a causal chain diagram to link genetic mutations to cellular outcomes, supported by empirical data from Kempthorne et al. 2020.frame_problem
27
Slide 27 of a pitch deck. Contains three distinct chart/image panels showing efficacy of VGL101.present_solution
28
PoM = Proof of Mechanism; ALSP = Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.analyze_data
29
Scientific slide presenting microscopy and imaging data (A-D) to support a mechanism of action.illustrate_case
30
The slide uses a combination of longitudinal imaging and scatter/dot plots to establish clinical validity for biomarkers.frame_problem
31
The diagram uses a network-style flow to show how early-stage research and patient engagement feed into later-stage clinical trials.plan_implementation
32
The slide uses a hierarchical pillar-and-tactic structure to map organizational goals to specific activities.plan_implementation
33
Includes footnotes regarding clinical trial status and regulatory expectations.plan_implementation
34
The slide uses a top-down funnel approach to narrow the market from general leukodystrophies to the specific ALSP indication.size_opportunity
Open slide detailBeat · Market Size
36
The slide presents a technical specification table for a drug development program.present_solution
37
The chart shows dose-response curves for VG-2862 concentration vs. pSYK activation signal, comparing 'No Fab' (control) against four different Fabs.present_solution
38
The slide shows four dose-response plots. The EC50 values are explicitly labeled for the three active cases.present_solution
39
The data highlights the specificity of the drug candidate for brain tissue over peripheral circulation.show_traction
40
The slide uses box plots to compare control vs VG-3440 across six different biological metrics.analyze_data
41
The slide uses checkmarks for completed milestones and empty squares for future milestones, effectively acting as a status tracker.plan_implementation
43
The slide uses a hub-and-spoke diagram to visualize the market opportunity for a platform technology targeting microglial function.size_opportunity
44
Includes a Manhattan plot (GWAS) and immunohistochemistry images with quantitative analysis of microglia clustering.establish_context
45
Slide contains multiple microscopy images and bar charts showing experimental results from Yuan et al (2016) and Wang et al (2020).analyze_data
46
The slide presents histological images and quantitative dot plots comparing Trem2 wild-type, heterozygous, and knockout mice.analyze_data
48
The slide uses a linear process flow to illustrate the drug development strategy.plan_implementation
49
The slide uses a structured matrix to justify pipeline expansion by highlighting significant unmet medical needs across three rare diseases.compare_peers
50
The slide uses a causal chain diagram to explain the disease progression and a biological process diagram to explain the therapeutic intervention.present_solution
52
The slide uses a checklist format to indicate progress, with the first item marked as completed.plan_implementation
53
The slide uses a Venn-like overlapping circle layout to connect scientific rationale, team capability, and mission.summarize